by The global analgesics market is estimated to be valued at US$ 51.10 billion in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031. Analgesics refer to a diverse group of drugs that are used to relieve pain by either raising the pain threshold or inhibiting pain perception. They have wide applications across numerous therapeutic areas such as musculoskeletal disorders, surgical procedures, cancer pain, dental pain, migraine, and other conditions. Growing prevalence of chronic pain conditions such as arthritis, lower back pain, and cancer-related pain will drive increased consumption of analgesic drugs in the foreseeable future.
Key Takeaways
Key players operating in the global analgesics market are F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aurobindo Pharma, Bausch Health Companies Inc., Amneal Pharmaceuticals LLC., Apotex Inc., Eli Lilly and Company, Cipla Inc., Lupin. Major players are focusing on developing new drug formulations and expanding their geographical presence through acquisitions and collaborations. For instance, in 2021, GSK completed the acquisition of Sierra Oncology expanding its oncology portfolio.
Key opportunities in the analgesics market include launch of novel non-opioid drugs for improved pain management, increasing use of generic analgesics owing to their cost-effectiveness and patent expiries of major blockbuster drugs providing opportunities for biosimilars. The Global Analgesics Market demand is also likely to witness high growth in emerging economies of Asia Pacific and Latin America, given the improving access to healthcare infrastructure and increasing disease burden.
The increasing geriatric population worldwide susceptible to chronic pain conditions as well as expanding healthcare spending is fueling the growth of the analgesics market. Additionally, growing number of surgical procedures performed annually will continue augmenting the demand for post-operative pain relief drugs. However, stringent regulations governing opioids use may hinder the market growth to some extent over the forecast period. Overall, innovations delivering safer and more effective pain therapies will augment the analgesics market opportunity going forward.
PEST Analysis
Political: Regulations around sale and distribution of pain killers are likely to impact the market. Rules regarding patent protections and pricing pressures also affect industry players.
Economic: Market growth is tied to economic conditions and spending power of customers. Recessions may dampen demand from consumers and healthcare systems.
Social: Aging populations and prevalence of chronic diseases drive needs for pain relief medications. Social acceptance of relieving pain influences consumption patterns.
Technological: Innovation in drug delivery methods and active ingredients help address unmet needs more effectively. Precision therapies enable targeted relief.
The Global Analgesics Market Regional Analysis shows that North America accounts for the largest share of the global analgesics market in terms of value. High healthcare expenditure, easy access to treatments, and growing chronic pain prevalence support market growth.
The Asia Pacific region is poised to experience the fastest growth in the analgesics market during the forecast period. Rapid economic development, rising living standards, expanding patient pools and improving healthcare infrastructure present lucrative opportunities.
Most of the analgesics market value is concentrated in the developed markets of North America and Western Europe currently. However, growth prospects appear higher in developing Asian countries and Latin American nations over the coming years. While cost constraints persist in some emerging regions, enhanced access and rising disposable incomes are expected to fuel higher analgesics consumption.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
